학술논문
Patient-reported outcomes based on discontinuation or continuous treatment with natalizumab: New York State Multiple Sclerosis Consortium (NYSMSC) study
Document Type
Article
Author
Source
In Journal of the Neurological Sciences 15 December 2023 455
Subject
Language
ISSN
0022-510X